Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States

被引:34
|
作者
Fejzo, Marlena S. [1 ,3 ]
MacGibbon, Kimber W. [2 ]
Mullin, Patrick M. [3 ]
机构
[1] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA
[2] Hyperemesis Educ & Res Fdn, Damascus, OR USA
[3] Univ So Calif, Keck Sch Med, Dept Maternal Fetal Med, Los Angeles, CA 90033 USA
关键词
Ondansetron; Hyperemesis gravidarum; Pregnancy; Nausea; Birth defect; Morning sickness; Heart defect; Cleft; NAUSEA;
D O I
10.1016/j.reprotox.2016.04.027
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This is an analysis of fetal outcome in pregnancies exposed to ondansetron to treat Hyperemesis Gravidarum (HG). In this retrospective cohort study, U.S. data on outcome were collected on 1070 pregnancies exposed to ondansetron and compared to outcomes in two control groups: 771 pregnancies in women with a history of HG with no ondansetron exposure and 1555 pregnancies with neither a history of HG nor ondansetron exposure. Ventricular septal defects were reported in 2/952 of infants in the HG/Ondansetron-exposure group and 4/1286 in the No HG/No Ondansetron-exposure group. Cleft palate was reported in 1/952 live births in the HG/Ondansetron and 2/1286 in the No HG/No Ondansetron-exposure groups. Women with a history of HG who took ondansetron reported less miscarriages and terminations, and higher live birth rates. The overall results do not support evidence of teratogenicity of ondansetron. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 50 条
  • [41] Pregnancy and Birth Outcomes in the United States
    Wisner, Kirsten
    MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING, 2023, 48 (03) : 168 - 168
  • [42] Fetal Inherited Thrombophilic Factors and Adverse Pregnancy Outcomes
    Cecati, Monia
    Saccucci, Franca
    Emanuelli, Monica
    Giannubilo, Stefano
    Stortoni, Piergiorgio
    Lorenzi, Sara
    Tranquilli, Andrea
    HYPERTENSION IN PREGNANCY, 2008, 27 (04) : 492 - 492
  • [43] Pregnancy in renal disease: Adverse fetal and maternal outcomes
    Fischer, MJ
    Hebert, JR
    Lehnerz, SD
    Parikh, CR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 195A - 195A
  • [44] Risk of Adverse Pregnancy Outcomes Among Pregnant Individuals With Gestational Diabetes by Race and Ethnicity in the United States, 2014-2020
    Venkatesh, Kartik K.
    Lynch, Courtney D.
    Powe, Camille E.
    Costantine, Maged M.
    Thung, Stephen F.
    Gabbe, Steven G.
    Grobman, William A.
    Landon, Mark B.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (14): : 1356 - 1367
  • [46] Fetal hydrops and the risk of adverse maternal outcomes
    Burwick, Richard M.
    Penfield, Christina A.
    Esakoff, Tania A.
    Pilliod, Rachel A.
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S396 - S397
  • [47] Pregnancy Outcomes in Women Dispensed Ondansetron in Pregnancy
    Colvin, L.
    Slack-Smith, L.
    Stanley, F.
    Bower, C.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2012, 94 (05) : 404 - 404
  • [48] Pregnancy Outcomes in Women Dispensed Ondansetron in Pregnancy
    Colvin, Lyn
    Slack-Smith, Linda
    Stanley, Fiona J.
    Bower, Carol
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 14 - 14
  • [49] Black Father's Influence on Adverse Pregnancy Outcomes in the United States: A Narrative Synthesis of Literature
    Hill, Ashley V.
    Balascio, Phoebe
    Moore, Mikaela
    Blackmon, Brandi
    Alston, Tasha
    Anto-Ocrah, Martina
    AMERICAN JOURNAL OF MENS HEALTH, 2024, 18 (04)
  • [50] Risk Factors for Adverse Pregnancy Outcomes in Reduced Fetal Movement: An IPD Meta-Analysis
    Lu, Yongyi
    Palin, Victoria
    Heazell, Alexander
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2025,